These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33356166)

  • 1. Time-Resolved Luminescent High-Throughput Screening Platform for Lysosomotropic Compounds in Living Cells.
    Wu KJ; Wu C; Chen F; Cheng SS; Ma DL; Leung CH
    ACS Sens; 2021 Jan; 6(1):166-174. PubMed ID: 33356166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high content screening assay for identifying lysosomotropic compounds.
    Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
    Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lysosomotropic molecules on cellular homeostasis.
    Kuzu OF; Toprak M; Noory MA; Robertson GP
    Pharmacol Res; 2017 Mar; 117():177-184. PubMed ID: 28025106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell killing by lysosomotropic detergents.
    Miller DK; Griffiths E; Lenard J; Firestone RA
    J Cell Biol; 1983 Dec; 97(6):1841-51. PubMed ID: 6196369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
    Lu S; Sung T; Lin N; Abraham RT; Jessen BA
    PLoS One; 2017; 12(3):e0173771. PubMed ID: 28301521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides.
    Wolf M; Bauder-Wüst U; Eskerski H; Bauer C; Eisenhut M
    Melanoma Res; 2007 Apr; 17(2):61-73. PubMed ID: 17496781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Lysosomotropic Dyes to Exclude Lysosomal Membrane Permeabilization.
    Repnik U; Česen MH; Turk B
    Cold Spring Harb Protoc; 2016 May; 2016(5):. PubMed ID: 27140914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Intracellular Accumulation and Retention of Lysosomotropic Macrocyclic Compounds by High-Throughput Imaging of Lysosomal Changes.
    Easwaranathan A; Inci B; Ulrich S; Brunken L; Nikiforova V; Norinder U; Swanson S; Munic Kos V
    J Pharm Sci; 2019 Jan; 108(1):652-660. PubMed ID: 30419273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform.
    Nao SC; Huang LS; Shiu-Hin Chan D; Wang X; Li GD; Wu J; Wong CY; Wang W; Leung CH
    Bioorg Chem; 2024 Mar; 144():107176. PubMed ID: 38330721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
    Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
    Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death.
    Villamil Giraldo AM; Appelqvist H; Ederth T; Öllinger K
    Biochem Soc Trans; 2014 Oct; 42(5):1460-4. PubMed ID: 25233432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane.
    Stark M; Silva TFD; Levin G; Machuqueiro M; Assaraf YG
    Cells; 2020 Apr; 9(5):. PubMed ID: 32349204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review).
    Agostinelli E; Seiler N
    Int J Oncol; 2007 Sep; 31(3):473-84. PubMed ID: 17671672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
    Schneider P; Korolenko TA; Busch U
    Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
    Pisonero-Vaquero S; Medina DL
    Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
    Firestone RA; Pisano JM; Bonney RJ
    J Med Chem; 1979 Sep; 22(9):1130-3. PubMed ID: 114658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Guntuku L; Gangasani JK; Thummuri D; Borkar RM; Manavathi B; Ragampeta S; Vaidya JR; Sistla R; Vegi NGM
    Oncogene; 2019 Jan; 38(4):581-595. PubMed ID: 30166591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic iridium(III) complexes as one- and two-photon phosphorescent trackers to monitor autophagic lysosomes.
    He L; Tan CP; Ye RR; Zhao YZ; Liu YH; Zhao Q; Ji LN; Mao ZW
    Angew Chem Int Ed Engl; 2014 Nov; 53(45):12137-41. PubMed ID: 25244053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
    Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
    Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuroblastoma (SH-SY5Y) cells are highly sensitive to the lysosomotropic aldehyde 3-aminopropanal.
    Yu Z; Li W; Hillman J; Brunk UT
    Brain Res; 2004 Aug; 1016(2):163-9. PubMed ID: 15246852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.